Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE

Original Publication: Lausanne : Frontiers Media S.A., [2014]-

Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia in response to nutritional excess leading to hypoxia, adipokine dysregulation, and subsequent low-grade inflammation that is characterized by increased infiltration and activation of innate and adaptive immune cells. The specific localization, physiology, susceptibility to inflammation and the heterogeneity of the inflammatory cell population of each adipose depot are unique and thus dictate the possible complications of adipose tissue chronic inflammation. Several lines of evidence link visceral and particularly perivascular, pericardial, and perirenal adipose tissue inflammation to the development of metabolic syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. In addition to the implication of the immune system in the regulation of adipose tissue function, adipose tissue immune components are pivotal in detrimental or otherwise favorable adipose tissue remodeling and thermogenesis. Adipose tissue resident and infiltrating immune cells undergo metabolic and morphological adaptation based on the systemic energy status and thus a better comprehension of the metabolic regulation of immune cells in adipose tissues is pivotal to address complications of chronic adipose tissue inflammation. In this review, we discuss the role of adipose innate and adaptive immune cells across various physiological and pathophysiological states that pertain to the development or progression of cardiovascular diseases associated with metabolic disorders. Understanding such mechanisms allows for the exploitation of the adipose tissue-immune system crosstalk, exploring how the adipose immune system might be targeted as a strategy to treat cardiovascular derangements associated with metabolic dysfunctions.
(Copyright © 2020 AlZaim, Hammoud, Al-Koussa, Ghazi, Eid and El-Yazbi.)

Sci Immunol. 2019 May 3;4(35):. (PMID: 31053655)
Domest Anim Endocrinol. 2007 Apr;32(3):235-45. (PMID: 16857338)
Nat Med. 2011 May;17(5):610-7. (PMID: 21499269)
Br J Nutr. 2013 Jun;109(11):2031-5. (PMID: 23069270)
Cell Metab. 2020 Aug 4;32(2):243-258.e6. (PMID: 32516575)
Acta Physiol (Oxf). 2011 May;202(1):21-8. (PMID: 21251239)
Acta Physiol Scand. 1968 Apr;72(4):425-32. (PMID: 4174120)
Sci Rep. 2018 Mar 16;8(1):4677. (PMID: 29549282)
G Ital Dermatol Venereol. 2017 Aug;152(4):342-347. (PMID: 27284777)
Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E504-E509. (PMID: 30620639)
Nutr J. 2015 Oct 29;14:112. (PMID: 26514124)
Mol Metab. 2019 Jun;24:30-43. (PMID: 31079959)
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5133-8. (PMID: 23479618)
Cell Metab. 2014 Jan 7;19(1):162-171. (PMID: 24374218)
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564-8. (PMID: 8962092)
J Immunol. 2010 Dec 1;185(11):6947-59. (PMID: 21037091)
J Clin Endocrinol Metab. 2013 Sep;98(9):E1448-55. (PMID: 23824424)
Diabetes. 2003 Feb;52(2):268-76. (PMID: 12540596)
Int J Mol Sci. 2019 Sep 18;20(18):. (PMID: 31540528)
Sci Rep. 2016 Feb 26;6:22193. (PMID: 26917360)
Adv Exp Med Biol. 2017;960:221-245. (PMID: 28585201)
Immunity. 2016 Aug 16;45(2):428-41. (PMID: 27496734)
J Cell Mol Med. 2019 May;23(5):3375-3385. (PMID: 30772951)
Cytokine. 2008 Oct;44(1):141-8. (PMID: 18723371)
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1631-6. (PMID: 24925977)
J Biol Chem. 2011 Oct 7;286(40):34552-8. (PMID: 21849507)
Arterioscler Thromb Vasc Biol. 2009 May;29(5):781-6. (PMID: 19229071)
J Immunol. 2016 Mar 15;196(6):2552-60. (PMID: 26873994)
Sci Signal. 2019 Feb 26;12(570):. (PMID: 30808817)
J Biol Chem. 2012 Jul 13;287(29):24378-86. (PMID: 22645141)
Nat Rev Immunol. 2020 Jan;20(1):55-70. (PMID: 31406325)
Eur J Immunol. 2009 Jul;39(7):1893-901. (PMID: 19585513)
Trends Endocrinol Metab. 2016 Jan;27(1):1-10. (PMID: 26643658)
Immunity. 2015 Jul 21;43(1):161-74. (PMID: 26092469)
Immunology. 2015 Jun;145(2):213-24. (PMID: 25545227)
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1046-1049. (PMID: 28473440)
J Leukoc Biol. 2020 Jul;108(1):123-128. (PMID: 32170879)
Diabetes. 2019 Dec;68(12):2247-2258. (PMID: 31492661)
Front Immunol. 2019 Feb 07;10:171. (PMID: 30792718)
JAMA. 2004 Apr 14;291(14):1730-7. (PMID: 15082700)
Diabetes Obes Metab. 2014 Dec;16(12):1269-73. (PMID: 25039318)
Cell Rep. 2019 Jun 4;27(10):3034-3048.e5. (PMID: 31167146)
J Clin Endocrinol Metab. 1982 Feb;54(2):254-60. (PMID: 7033275)
Diabetes. 2002 Oct;51(10):2968-74. (PMID: 12351435)
J Biol Chem. 2001 Jul 6;276(27):25096-100. (PMID: 11342529)
Diabetes. 2013 Aug;62(8):2762-72. (PMID: 23493569)
J Diabetes Complications. 2019 Aug;33(8):535-538. (PMID: 31204245)
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):96-102. (PMID: 24291610)
Biochem Biophys Res Commun. 1986 Aug 14;138(3):1044-50. (PMID: 3753485)
Semin Immunopathol. 2019 Jul;41(4):461-475. (PMID: 31025085)
Oxid Med Cell Longev. 2018 Jan 31;2018:9389784. (PMID: 29643979)
Biomarkers. 2011 Dec;16(8):657-62. (PMID: 21988056)
Basic Res Cardiol. 2013 Jan;108(1):315. (PMID: 23212557)
Am J Physiol Lung Cell Mol Physiol. 2004 Sep;287(3):L497-502. (PMID: 15145787)
Biochem Soc Trans. 2005 Nov;33(Pt 5):1078-81. (PMID: 16246049)
Biochimie. 2016 Jun;125:259-66. (PMID: 26542285)
Nat Med. 2009 Aug;15(8):930-9. (PMID: 19633656)
Vasc Health Risk Manag. 2013;9:105-16. (PMID: 23576873)
Am J Physiol Endocrinol Metab. 2012 Oct 15;303(8):E937-49. (PMID: 22895783)
Immunol Rev. 2020 May;295(1):101-113. (PMID: 32237081)
Endocrinology. 2010 Nov;151(11):5267-78. (PMID: 20739398)
Am J Physiol Regul Integr Comp Physiol. 2005 May;288(5):R1220-5. (PMID: 15604306)
Cell Metab. 2016 Jan 12;23(1):27-47. (PMID: 26771115)
Genes Dev. 2017 Apr 15;31(8):774-786. (PMID: 28465358)
J Endocrinol. 2014 Mar 13;221(1):111-9. (PMID: 24492466)
Cardiovasc Diabetol. 2011 Nov 22;10:103. (PMID: 22108456)
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2616-23. (PMID: 21836066)
Cardiovasc Diabetol. 2018 May 1;17(1):56. (PMID: 29712560)
Eur J Med Chem. 2019 Apr 1;167:562-582. (PMID: 30818268)
Cell Metab. 2019 Jan 8;29(1):27-37. (PMID: 30503034)
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jul;1864(7):1017-1030. (PMID: 30953761)
J Transl Med. 2016 Oct 13;14(1):290. (PMID: 27737674)
Diabetes. 2015 Feb;64(2):593-603. (PMID: 25249575)
Physiol Res. 2016;65(1):23-32. (PMID: 26596323)
Am J Physiol Endocrinol Metab. 2015 May 15;308(10):E891-8. (PMID: 25783894)
Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E678-E697. (PMID: 27555298)
Curr Opin Pharmacol. 2017 Dec;37:35-40. (PMID: 28843953)
Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):27-35. (PMID: 19029992)
Diabetes. 2012 Jul;61(7):1680-90. (PMID: 22474027)
Sci Rep. 2019 Aug 19;9(1):12069. (PMID: 31427677)
Hypertension. 2019 Feb;73(2):458-468. (PMID: 30624990)
Biochem Soc Trans. 1983 Jan;11(1):52-6. (PMID: 6337886)
J Immunol. 2013 Dec 1;191(11):5349-53. (PMID: 24166975)
Acta Physiol (Oxf). 2016 Aug;217(4):311-24. (PMID: 27064138)
Front Immunol. 2019 May 22;10:1173. (PMID: 31191541)
Oncotarget. 2017 Mar 28;8(13):20706-20718. (PMID: 28157701)
Diabetes. 2007 Jun;56(6):1655-61. (PMID: 17329619)
J Clin Lipidol. 2019 Mar - Apr;13(2):301-307. (PMID: 30773418)
Biomed Pharmacother. 2018 Sep;105:182-186. (PMID: 29857297)
Cell Death Differ. 2020 Jul;27(7):2248-2262. (PMID: 32001780)
J Allergy Clin Immunol. 2020 Feb;145(2):502-517.e5. (PMID: 31738991)
J Biol Chem. 2016 Nov 4;291(45):23390-23402. (PMID: 27621315)
Cell Metab. 2013 Nov 5;18(5):759-766. (PMID: 24209772)
Front Physiol. 2020 Jan 29;10:1607. (PMID: 32063863)
Nat Med. 2014 Nov;20(11):1327-33. (PMID: 25282359)
Dis Model Mech. 2018 Mar 28;11(3):. (PMID: 29590639)
J Immunol. 2015 May 15;194(10):4777-83. (PMID: 25870243)
Transl Res. 2019 Dec;214:121-143. (PMID: 31408626)
FASEB J. 2019 Nov;33(11):11821-11835. (PMID: 31355683)
J Exp Med. 2016 Jul 25;213(8):1409-18. (PMID: 27432938)
Biochem Biophys Res Commun. 2009 Jul 10;384(4):482-5. (PMID: 19422792)
FEBS Lett. 2017 Oct;591(19):2992-3006. (PMID: 28685841)
Int Arch Allergy Immunol. 2010;152 Suppl 1:22-31. (PMID: 20523060)
Nat Immunol. 2018 May;19(5):464-474. (PMID: 29670241)
Cell Death Dis. 2015 Aug 13;6:e1856. (PMID: 26270350)
Diabetes. 2018 Nov;67(11):2361-2376. (PMID: 30181158)
Cell Metab. 2015 Aug 4;22(2):279-90. (PMID: 26166748)
Arch Endocrinol Metab. 2017 Dec;61(6):515-523. (PMID: 28977161)
Cardiovasc Diabetol. 2016 Jun 28;15:90. (PMID: 27352781)
Exerc Immunol Rev. 2010;16:105-18. (PMID: 20839495)
Circ Res. 2020 May 22;126(11):1565-1589. (PMID: 32437306)
Neurosci Lett. 2000 Oct 27;293(2):107-10. (PMID: 11027845)
Cell Immunol. 2018 Aug;330:183-187. (PMID: 29807623)
Hypertens Res. 2011 Dec;34(12):1309-12. (PMID: 21814208)
J Immunol. 2016 Nov 1;197(9):3650-3661. (PMID: 27683748)
Endocrinology. 2005 Apr;146(4):1764-71. (PMID: 15677759)
Antioxid Redox Signal. 2011 Oct 1;15(7):1779-88. (PMID: 21091073)
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1304-10. (PMID: 18420999)
Nat Immunol. 2015 Mar;16(3):276-85. (PMID: 25599561)
Cell. 2014 Jun 5;157(6):1279-1291. (PMID: 24906147)
J Exp Med. 2013 Mar 11;210(3):535-49. (PMID: 23420878)
FEBS Lett. 2005 Dec 19;579(30):6821-6. (PMID: 16325814)
Endocrinology. 2013 Oct;154(10):3525-38. (PMID: 23885013)
Cell Rep. 2015 Oct 27;13(4):760-770. (PMID: 26489460)
Metabolism. 2010 Jan;59(1):93-9. (PMID: 19765775)
Circ Res. 2015 Jul 17;117(3):e28-39. (PMID: 26082558)
Nat Commun. 2018 Nov 30;9(1):5099. (PMID: 30504842)
J Urol. 2016 Apr;195(4 Pt 1):1152-9. (PMID: 26417644)
Immunity. 2016 Feb 16;44(2):406-21. (PMID: 26885861)
Biochem Pharmacol. 2020 Apr;174:113830. (PMID: 32001235)
Front Pharmacol. 2012 Jun 05;3:103. (PMID: 22679436)
Can J Physiol Pharmacol. 2018 Aug;96(8):751-756. (PMID: 29558631)
J Biol Chem. 2016 Feb 5;291(6):2566-75. (PMID: 26631720)
Immunity. 2012 Sep 21;37(3):574-87. (PMID: 22981538)
PLoS One. 2014 Jan 30;9(1):e87936. (PMID: 24498225)
Chem Biol. 2011 Feb 25;18(2):264-74. (PMID: 21338923)
J Clin Invest. 2012 Sep;122(9):3343-54. (PMID: 22863618)
Obesity (Silver Spring). 2008 Jul;16(7):1481-6. (PMID: 18421280)
BMC Med Genet. 2011 Apr 28;12:60. (PMID: 21526992)
Front Immunol. 2017 Jun 19;8:639. (PMID: 28674530)
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1038-46. (PMID: 18765677)
J Physiol Biochem. 2020 May;76(2):185-192. (PMID: 31853729)
J Biol Chem. 2011 Apr 15;286(15):12983-90. (PMID: 21317437)
Biochem Biophys Res Commun. 2005 Oct 7;335(4):1254-63. (PMID: 16115611)
Elife. 2019 Oct 23;8:. (PMID: 31644425)
Sci Rep. 2019 Jun 17;9(1):8658. (PMID: 31209239)
Atherosclerosis. 2017 Aug;263:82-91. (PMID: 28623741)
Diabetes. 2016 Sep;65(9):2624-38. (PMID: 27284106)
Trends Parasitol. 2019 Oct;35(10):795-808. (PMID: 31492623)
Sci Rep. 2020 Jan 20;10(1):670. (PMID: 31959796)
Trends Endocrinol Metab. 2014 Jul;25(7):348-55. (PMID: 24746980)
Biosci Rep. 2016 Jan 21;36(2):. (PMID: 26795216)
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12228-E12234. (PMID: 30530672)
J Lipid Res. 2018 May;59(5):784-794. (PMID: 29599420)
FEBS Open Bio. 2013 Nov 28;4:18-24. (PMID: 24319653)
Diabetologia. 2019 Jun;62(6):1048-1064. (PMID: 31011777)
Front Physiol. 2018 Dec 11;9:1781. (PMID: 30618796)
JCI Insight. 2018 Mar 8;3(5):. (PMID: 29515042)
J Innate Immun. 2016;8(6):601-616. (PMID: 27544668)
Nature. 2003 Jun 12;423(6941):762-9. (PMID: 12802337)
Sci Rep. 2017 Nov 22;7(1):16082. (PMID: 29167565)
Lancet. 2005 Oct 8;366(9493):1279-89. (PMID: 16214598)
JCI Insight. 2019 Apr 18;4(8):. (PMID: 30996144)
Curr Atheroscler Rep. 2018 Apr 25;20(6):27. (PMID: 29696385)
Biochem J. 2008 Dec 1;416(2):161-77. (PMID: 18783346)
Thorac Cardiovasc Surg. 2014 Oct;62(7):554-60. (PMID: 24875807)
PLoS One. 2017 Feb 16;12(2):e0172271. (PMID: 28207876)
J Investig Med. 2013 Dec;61(8):1152-60. (PMID: 24141239)
PLoS One. 2014 Jan 24;9(1):e86744. (PMID: 24475175)
J Biol Chem. 2010 Feb 26;285(9):6153-60. (PMID: 20028977)
Trends Immunol. 2018 May;39(5):380-392. (PMID: 29478771)
FASEB J. 1998 Jan;12(1):57-65. (PMID: 9438411)
Am J Physiol Endocrinol Metab. 2014 Nov 1;307(9):E793-9. (PMID: 25184993)
J Biol Chem. 2015 Sep 4;290(36):22174-83. (PMID: 26198639)
Obesity (Silver Spring). 2006 Aug;14(8):1353-62. (PMID: 16988077)
Curr Obes Rep. 2019 Sep;8(3):210-219. (PMID: 30919312)
J Leukoc Biol. 2015 Jan;97(1):121-34. (PMID: 25395302)
Cell Physiol Biochem. 2017;42(5):2130-2143. (PMID: 28810263)
Inflamm Res. 2010 Feb;59(2):115-21. (PMID: 19693648)
Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4398-4405. (PMID: 29077154)
Proc Nutr Soc. 2001 Aug;60(3):329-39. (PMID: 11681807)
J Biol Chem. 2011 May 6;286(18):15652-65. (PMID: 21378161)
Curr Med Chem. 2021;28(11):2260-2300. (PMID: 32867639)
Biochim Biophys Acta. 2014 Sep;1841(9):1329-35. (PMID: 24960101)
Bull Exp Biol Med. 2017 Sep;163(5):608-611. (PMID: 28948552)
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2686-91. (PMID: 24492375)
BMB Rep. 2018 Dec;51(12):611-612. (PMID: 30463644)
Nature. 1979 Sep 6;281(5726):31-5. (PMID: 551265)
Circ J. 2017 Jun 23;81(7):920-928. (PMID: 28603178)
Nat Commun. 2020 Jan 23;11(1):438. (PMID: 31974378)
J Cardiovasc Transl Res. 2019 Oct;12(5):415-424. (PMID: 30835048)
Nat Immunol. 2016 Nov;17(11):1291-1299. (PMID: 27618553)
Chem Biol Interact. 2014 Jul 25;218:89-98. (PMID: 24835546)
Nat Immunol. 2011 May;12(5):408-15. (PMID: 21478880)
Transl Res. 2017 May;183:57-70. (PMID: 28130064)
iScience. 2018 Jul 27;5:99-109. (PMID: 30240649)
Front Immunol. 2020 Mar 13;11:448. (PMID: 32231670)
Nat Med. 2009 Aug;15(8):914-20. (PMID: 19633658)
Eur J Immunol. 2007 Aug;37(8):2337-48. (PMID: 17634954)
Clin Immunol. 2015 Oct;160(2):155-62. (PMID: 26073226)
Nutrition. 2015 May;31(5):691-6. (PMID: 25837214)
Nat Immunol. 2011 Nov;12(11):1045-54. (PMID: 21946417)
iScience. 2020 Jun 26;23(6):101161. (PMID: 32480126)
Circulation. 2012 Aug 28;126(9):1067-78. (PMID: 22855570)
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1438-1446. (PMID: 30218482)
Mediators Inflamm. 2017;2017:9067049. (PMID: 28458470)
Cell Metab. 2008 Oct;8(4):301-9. (PMID: 18840360)
N Engl J Med. 2017 Aug 17;377(7):644-657. (PMID: 28605608)
J Immunol. 2019 Jul 15;203(2):453-464. (PMID: 31160535)
Adipocyte. 2012 Oct 1;1(4):192-199. (PMID: 23700533)
Nat Immunol. 2014 Aug;15(8):749-757. (PMID: 24973821)
Obesity (Silver Spring). 2016 Jul;24(7):1438-45. (PMID: 27228052)
J Mol Med (Berl). 2015 Dec;93(12):1311-25. (PMID: 26138247)
J Clin Endocrinol Metab. 2006 Jan;91(1):295-9. (PMID: 16234302)
Biochem Pharmacol. 2016 Nov 1;119:8-16. (PMID: 27179976)
Br J Pharmacol. 2002 Nov;137(6):799-804. (PMID: 12411410)
Sci Rep. 2017 Mar 17;7:44571. (PMID: 28303919)
Adv Nutr. 2019 Mar 1;10(2):321-330. (PMID: 30753258)
Nat Immunol. 2015 Jan;16(1):85-95. (PMID: 25436972)
Angiology. 2019 Aug;70(7):584-593. (PMID: 30301366)
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1157-1167. (PMID: 31051284)
Biochem Biophys Res Commun. 1978 Jul 28;83(2):628-34. (PMID: 212061)
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1110-1122. (PMID: 32131612)
Cell Rep. 2019 Jul 16;28(3):792-803.e4. (PMID: 31315055)
Cell Metab. 2019 Sep 3;30(3):462-476.e6. (PMID: 31471173)
Nat Med. 2017 Nov;23(11):1309-1318. (PMID: 29035364)
Diabetes. 2013 Sep;62(9):3180-8. (PMID: 23733197)
Diabetes. 2017 Apr;66(4):835-847. (PMID: 28082459)
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H746-53. (PMID: 20061546)
Nat Rev Immunol. 2015 Jan;15(1):18-29. (PMID: 25534620)
J Biol Chem. 2012 Apr 20;287(17):13561-71. (PMID: 22396530)
Gastroenterology. 2017 Jun;152(8):1998-2010. (PMID: 28246016)
Immunity. 2017 Sep 19;47(3):466-480.e5. (PMID: 28916263)
Circ Res. 2018 Mar 2;122(5):693-700. (PMID: 29358227)
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):482-7. (PMID: 25550516)
Immunity. 2005 Nov;23(5):503-14. (PMID: 16286018)
Cells. 2022 Aug 17;11(16):. (PMID: 36010694)
Exp Biol Med (Maywood). 2014 Apr 9;239(8):954-965. (PMID: 24719379)
Leukemia. 2017 Dec;31(12):2678-2685. (PMID: 28490813)
Front Immunol. 2019 Sep 20;10:2099. (PMID: 31616403)
PLoS One. 2015 Feb 25;10(2):e0118534. (PMID: 25714366)
J Exp Med. 2002 Jun 3;195(11):1387-95. (PMID: 12045237)
Cell Metab. 2017 Sep 5;26(3):493-508.e4. (PMID: 28844880)
J Clin Invest. 2017 Mar 1;127(3):1019-1030. (PMID: 28192375)
Nat Immunol. 2020 Mar;21(3):331-342. (PMID: 32066950)
PLoS One. 2011 Jan 26;6(1):e16376. (PMID: 21298111)
Cell Mol Gastroenterol Hepatol. 2020;10(4):763-778. (PMID: 32629118)
Compr Physiol. 2017 Jun 18;7(3):765-781. (PMID: 28640441)
Sci Immunol. 2019 May 3;4(35):. (PMID: 31053654)
Nat Rev Mol Cell Biol. 2008 May;9(5):367-77. (PMID: 18401346)
J Clin Endocrinol Metab. 2012 Sep;97(9):E1677-85. (PMID: 22745246)
J Diabetes Investig. 2019 Mar;10(2):399-407. (PMID: 29957886)
Cell Mol Life Sci. 2014 Mar;71(6):1033-43. (PMID: 24127133)
J Mol Cell Cardiol. 2016 Oct;99:188-196. (PMID: 27638193)
Exp Ther Med. 2018 Dec;16(6):5327-5333. (PMID: 30542491)
BMB Rep. 2019 Jun;52(6):360-372. (PMID: 31186085)
Cancer Res. 2003 Nov 1;63(21):7436-42. (PMID: 14612543)
Biochem Pharmacol. 2014 Nov 1;92(1):131-41. (PMID: 25175736)
Mol Cell Endocrinol. 2017 Mar 5;443:63-71. (PMID: 28069536)
Nat Rev Immunol. 2004 May;4(5):371-9. (PMID: 15122202)
Biochem Biophys Res Commun. 2011 May 6;408(2):339-43. (PMID: 21514279)
Cell Metab. 2016 Apr 12;23(4):685-98. (PMID: 27050305)
J Clin Invest. 2015 Feb;125(2):665-80. (PMID: 25574840)
Cell Metab. 2006 Jul;4(1):13-24. (PMID: 16814729)
Cell Rep. 2020 Jul 7;32(1):107848. (PMID: 32640218)
Sci Rep. 2018 Mar 15;8(1):4607. (PMID: 29545532)
PLoS One. 2018 Jul 10;13(7):e0200444. (PMID: 29990379)
Metabolism. 2006 Oct;55(10):1375-81. (PMID: 16979409)
Nutrients. 2015 Sep 11;7(9):7651-75. (PMID: 26378571)
Cytokine. 2019 Jan;113:326-331. (PMID: 30337217)
Int J Obes (Lond). 2008 Feb;32(2):268-74. (PMID: 17878891)
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2637-43. (PMID: 25341798)
Biochem Biophys Res Commun. 2009 Dec 18;390(3):613-8. (PMID: 19850014)
Oncotarget. 2017 Nov 3;8(68):112565-112583. (PMID: 29348847)
Nat Immunol. 2016 Jun;17(6):656-65. (PMID: 27043409)
J Am Diet Assoc. 2011 Jan;111(1):84-91. (PMID: 21185969)
Cell. 2014 Jun 5;157(6):1292-1308. (PMID: 24906148)
Obesity (Silver Spring). 2015 Sep;23(9):1765-70. (PMID: 26242777)
Diabetes. 2016 Aug;65(8):2268-81. (PMID: 27207557)
J Exp Med. 2016 Apr 4;213(4):569-83. (PMID: 26976630)
PLoS One. 2014 Oct 15;9(10):e110108. (PMID: 25333972)
Cell Metab. 2017 Sep 5;26(3):475-492.e7. (PMID: 28877454)
Nature. 2020 Feb;578(7796):610-614. (PMID: 32076265)
Cell Metab. 2015 May 5;21(5):678-91. (PMID: 25955205)
Biochim Biophys Acta. 2014 Dec;1841(12):1691-9. (PMID: 25224322)
Circulation. 2013 Sep 10;128(11 Suppl 1):S113-20. (PMID: 24030394)
Nature. 2011 Nov 20;480(7375):104-8. (PMID: 22101429)
Front Immunol. 2019 Aug 27;10:1889. (PMID: 31507585)
Diabetes Obes Metab. 2013 Mar;15(3):204-12. (PMID: 22985213)
FASEB J. 2001 Jun;15(8):1357-66. (PMID: 11387233)
Int J Mol Med. 2015 Jan;35(1):177-86. (PMID: 25412187)
J Nutr Biochem. 2016 Jan;27:43-52. (PMID: 26456564)
Int J Obes (Lond). 2008 Feb;32(2):283-91. (PMID: 17726433)
J Clin Endocrinol Metab. 2005 Apr;90(4):2282-9. (PMID: 15671098)
Cell Metab. 2011 May 4;13(5):540-9. (PMID: 21531336)
Cell Metab. 2018 Aug 7;28(2):243-255.e5. (PMID: 30033198)
Br J Pharmacol. 1998 Oct;125(4):895-901. (PMID: 9831930)
Immunol Lett. 2018 Sep;201:1-13. (PMID: 30439477)
Front Physiol. 2017 Mar 23;8:179. (PMID: 28386236)
Cardiovasc Res. 2020 Jan 1;116(1):237-249. (PMID: 30874788)
Clin Endocrinol (Oxf). 2008 Dec;69(6):885-93. (PMID: 18410550)
Diabetologia. 2018 Apr;61(4):942-953. (PMID: 29333574)
Sci Rep. 2017 Nov 14;7(1):15566. (PMID: 29138472)
BMC Cardiovasc Disord. 2015 Sep 30;15:108. (PMID: 26419359)
Diabetes. 2002 Apr;51(4):1088-92. (PMID: 11916930)
PLoS One. 2015 Mar 18;10(3):e0120918. (PMID: 25785862)
J Immunol. 2020 Jul 1;205(1):45-55. (PMID: 32482712)
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10302-7. (PMID: 15231994)
Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E247-55. (PMID: 24326418)
Diabetes Care. 2016 Aug;39 Suppl 2:S244-52. (PMID: 27440839)
Mediators Inflamm. 2019 May 9;2019:5481725. (PMID: 31210749)
J Biol Chem. 2006 Oct 20;281(42):31894-908. (PMID: 16914547)
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4638-47. (PMID: 25313053)
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3532-41. (PMID: 17906103)
Annu Rev Physiol. 2010;72:219-46. (PMID: 20148674)
J Clin Invest. 2016 Dec 1;126(12):4626-4639. (PMID: 27820698)
Front Physiol. 2018 Feb 06;9:70. (PMID: 29467675)
Endocr J. 2017 Aug 30;64(8):787-796. (PMID: 28674284)
Am J Physiol Cell Physiol. 2011 Dec;301(6):C1360-7. (PMID: 21865589)
J Exp Med. 2019 Sep 2;216(9):1999-2009. (PMID: 31248899)
Circ Res. 2020 May 22;126(11):1590-1612. (PMID: 32437300)
J Appl Physiol (1985). 2018 Nov 1;125(5):1585-1593. (PMID: 30212302)
Horm Mol Biol Clin Investig. 2018 Jan 20;33(1):. (PMID: 29353263)
Trends Endocrinol Metab. 2012 Aug;23(8):407-15. (PMID: 22795937)
Cell Res. 2017 Nov;27(11):1309-1326. (PMID: 29039412)
Diabetes. 2005 Oct;54(10):2911-6. (PMID: 16186392)
Diabetologia. 2010 Jul;53(7):1461-71. (PMID: 20383694)
J Immunol. 2015 Feb 15;194(4):1954-62. (PMID: 25595780)
Front Immunol. 2014 Apr 23;5:187. (PMID: 24795729)
Circulation. 2012 Jun 26;125(25):3159-69. (PMID: 22653084)
Diabetes Obes Metab. 2014 Feb;16(2):147-58. (PMID: 23906415)
JCI Insight. 2017 Dec 7;2(23):. (PMID: 29212951)
Adipocyte. 2018;7(2):129-136. (PMID: 29509047)
Endocr Metab Immune Disord Drug Targets. 2015;15(3):196-205. (PMID: 25772174)
Curr Hypertens Rep. 2007 Mar;9(1):33-8. (PMID: 17362669)
Diabetologia. 2006 Aug;49(8):1909-14. (PMID: 16736128)
Diabetes Care. 2013 Nov;36(11):3396-404. (PMID: 23963895)
Diabetes. 2007 Jan;56(1):16-23. (PMID: 17192460)
Nat Med. 2016 Sep;22(9):1002-12. (PMID: 27455510)
J Clin Invest. 1982 Sep;70(3):550-7. (PMID: 7107894)
J Clin Endocrinol Metab. 2010 Jun;95(6):2845-50. (PMID: 20375213)
Obes Rev. 2010 Jan;11(1):11-8. (PMID: 19656312)
Biochem J. 2020 Feb 14;477(3):709-725. (PMID: 32059055)
Front Endocrinol (Lausanne). 2019 Jun 05;10:348. (PMID: 31231311)
Atherosclerosis. 2019 Jul;286:1-6. (PMID: 31051410)
Cell. 2019 Aug 22;178(5):1102-1114.e17. (PMID: 31442403)
Nutr Metab (Lond). 2017 Jan 5;14:3. (PMID: 28070205)
Obesity (Silver Spring). 2017 Nov;25(11):1881-1884. (PMID: 28922564)
J Biol Chem. 2015 Jun 5;290(23):14656-67. (PMID: 25931125)
Front Endocrinol (Lausanne). 2019 Mar 08;10:140. (PMID: 30906281)
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):814-20. (PMID: 21233449)
Nat Immunol. 2016 Mar;17(3):216-7. (PMID: 26882249)
Nat Immunol. 2014 Sep;15(9):846-55. (PMID: 25086775)
J Biol Chem. 2020 Feb 14;295(7):1926-1942. (PMID: 31914415)
Immunol Cell Biol. 2020 Nov;98(10):868-882. (PMID: 32696992)
Front Cell Dev Biol. 2019 Dec 20;7:329. (PMID: 31921842)
Nat Med. 2009 Aug;15(8):940-5. (PMID: 19633655)
J Immunol. 2015 Jun 1;194(11):5253-60. (PMID: 25917102)
Immunity. 2007 Feb;26(2):241-55. (PMID: 17307705)
J Exp Med. 2018 Nov 5;215(11):2778-2795. (PMID: 30282719)
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9765-70. (PMID: 20445103)
Diabetologia. 2006 Apr;49(4):744-7. (PMID: 16496121)
J Cell Physiol. 2018 Sep;233(9):6425-6440. (PMID: 29319160)
Nature. 2012 Jun 28;486(7404):549-53. (PMID: 22722857)
Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H906-17. (PMID: 26071547)
Clin Sci (Lond). 2020 Apr 17;134(7):827-851. (PMID: 32271386)
Cardiovasc Res. 2017 Jul 1;113(9):1009-1023. (PMID: 28838042)
J Immunol. 2010 Aug 1;185(3):1836-45. (PMID: 20581149)
Mol Cell Biol. 2009 Aug;29(16):4467-83. (PMID: 19546236)
Med Princ Pract. 2021;30(1):52-61. (PMID: 32438366)
Cardiovasc Pathol. 2020 Nov - Dec;49:107259. (PMID: 32692664)
Nat Immunol. 2018 Aug;19(8):871-884. (PMID: 29988090)
J Endocrinol Invest. 2019 Feb;42(2):117-128. (PMID: 29730732)
Mol Cell Biochem. 2016 Jun;417(1-2):67-74. (PMID: 27188183)
Nat Metab. 2020 Jan;2(1):50-61. (PMID: 32694683)
Acta Biochim Biophys Sin (Shanghai). 2020 Jul 10;52(7):768-775. (PMID: 32445465)
Diabetes Metab Res Rev. 2021 Mar;37(3):e3383. (PMID: 32652811)
J Biol Chem. 1995 Nov 10;270(45):26746-9. (PMID: 7592907)
Am J Physiol Lung Cell Mol Physiol. 2009 Apr;296(4):L624-34. (PMID: 19168575)
Cell Rep. 2017 Aug 15;20(7):1654-1666. (PMID: 28813676)
Immunity. 2009 Sep 18;31(3):457-68. (PMID: 19631565)
J Clin Biochem Nutr. 2018 Nov;63(3):181-191. (PMID: 30487667)
Immunotargets Ther. 2016 May 23;5:47-56. (PMID: 27529061)
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1723-30. (PMID: 24947528)
J Biol Chem. 2010 Mar 5;285(10):7153-64. (PMID: 20028987)
Nutrition. 2019 Mar;59:1-6. (PMID: 30415157)
Nat Rev Immunol. 2017 Dec;17(12):746-760. (PMID: 28891557)
Obes Rev. 2018 May;19(5):686-697. (PMID: 29334696)
Am J Med Sci. 2020 Sep;360(3):222-228. (PMID: 32591091)
FASEB J. 2019 Feb;33(2):2553-2562. (PMID: 30285581)
Cell Physiol Biochem. 2016;38(3):1257-66. (PMID: 26982979)
Cell. 2014 Jun 5;157(6):1339-1352. (PMID: 24906151)
Metabolism. 2000 Oct;49(10):1301-8. (PMID: 11079820)
Eur J Immunol. 2010 Aug;40(8):2296-307. (PMID: 20468007)
Mol Cell Endocrinol. 2016 Jan 5;419:235-43. (PMID: 26523509)
Cell Metab. 2015 Jan 6;21(1):51-64. (PMID: 25565205)
J Innate Immun. 2020;12(1):31-46. (PMID: 31786568)
Diabetes. 2017 May;66(5):1237-1246. (PMID: 28250021)
Sci Rep. 2020 Mar 25;10(1):5386. (PMID: 32214150)
Mediators Inflamm. 2016;2016:1698071. (PMID: 28077915)
J Clin Endocrinol Metab. 2014 Dec;99(12):E2772-9. (PMID: 25299843)
Physiol Rev. 2019 Oct 1;99(4):1701-1763. (PMID: 31339053)
Science. 2004 May 21;304(5674):1154-8. (PMID: 15155948)
J Hepatol. 2014 Jan;60(1):175-82. (PMID: 23973929)
Mediators Inflamm. 2010;2010:568343. (PMID: 20368778)
PLoS One. 2014 Mar 18;9(3):e92450. (PMID: 24642966)
Cell Metab. 2014 Mar 4;19(3):484-97. (PMID: 24606903)
Cell. 2018 Jul 12;174(2):285-299.e12. (PMID: 29887374)
Cancer Cell. 2009 Sep 8;16(3):183-94. (PMID: 19732719)
Nat Immunol. 2014 Apr;15(4):323-32. (PMID: 24562310)
Int J Med Sci. 2017 Jul 20;14(9):891-895. (PMID: 28824327)
Front Cardiovasc Med. 2020 Feb 25;7:22. (PMID: 32158768)
Clin Nutr. 2018 Dec;37(6 Pt A):1871-1878. (PMID: 29258678)
J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91. (PMID: 12050251)
Obesity (Silver Spring). 2017 Jun;25(6):1042-1049. (PMID: 28429889)
J Immunol. 2011 Mar 15;186(6):3299-303. (PMID: 21317389)
Inflamm Res. 2019 Nov;68(11):915-932. (PMID: 31363792)
Obesity (Silver Spring). 2015 Aug;23(8):1671-9. (PMID: 26179979)
Metabolism. 2017 May;70:12-22. (PMID: 28403936)
J Biol Chem. 2012 Jun 1;287(23):18965-73. (PMID: 22514273)
J Biol Chem. 2010 Dec 17;285(51):39691-701. (PMID: 20952387)
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1340-6. (PMID: 20395594)
Front Physiol. 2017 Sep 22;8:719. (PMID: 28970806)
Diabet Med. 2006 Sep;23(9):967-73. (PMID: 16922702)
Science. 2011 Apr 8;332(6026):243-7. (PMID: 21436399)
Cell Death Differ. 2015 Mar;22(3):445-56. (PMID: 25323583)
Front Immunol. 2018 Feb 16;9:202. (PMID: 29503646)
J Immunol. 2003 Feb 15;170(4):1964-72. (PMID: 12574365)
Clin Chim Acta. 2015 Aug 25;448:98-106. (PMID: 26079253)
Immunity. 2017 Nov 21;47(5):875-889.e10. (PMID: 29166588)
Immunity. 2018 Jun 19;48(6):1195-1207.e6. (PMID: 29907525)
Cell Mol Life Sci. 2001 Mar;58(3):470-6. (PMID: 11315192)
Lipids Health Dis. 2011 Nov 03;10:198. (PMID: 22051061)
Mediators Inflamm. 2017;2017:9029327. (PMID: 29386753)
Cell Metab. 2014 Feb 4;19(2):181-92. (PMID: 24440038)
Diabetologia. 2011 Oct;54(10):2660-8. (PMID: 21779871)
Oncotarget. 2017 Jan 31;8(5):8947-8979. (PMID: 27894098)
J Am Heart Assoc. 2014 Mar 04;3(2):e000582. (PMID: 24595191)
Cell Metab. 2018 Jun 05;27(6):1212-1221.e3. (PMID: 29754952)
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7439-7448. (PMID: 30910955)
Cell Metab. 2018 Mar 6;27(3):588-601.e4. (PMID: 29514067)
J Asthma. 2013 Oct;50(8):828-35. (PMID: 23777560)
Med Sci Sports Exerc. 2013 Sep;45(9):1684-93. (PMID: 23954991)
Aging Cell. 2018 Apr;17(2):. (PMID: 29383825)
J Clin Endocrinol Metab. 2004 Aug;89(8):3872-8. (PMID: 15292320)
Endocr Regul. 2016 Jul;50(3):137-44. (PMID: 27560796)
Cardiovasc Diabetol. 2011 Oct 07;10:87. (PMID: 21981776)
J Exp Med. 2007 Oct 1;204(10):2449-60. (PMID: 17875676)
Diabetes Care. 2007 May;30(5):1278-80. (PMID: 17261750)
J Immunol. 2014 Apr 15;192(8):3626-36. (PMID: 24616478)
N Engl J Med. 2016 Jul 28;375(4):311-22. (PMID: 27295427)
Trends Pharmacol Sci. 2018 Jun;39(6):536-546. (PMID: 29628274)
Diabetes Ther. 2018 Apr;9(2):583-612. (PMID: 29417495)
Nat Immunol. 2015 Apr;16(4):376-85. (PMID: 25729921)
Am J Physiol. 1994 Apr;266(4 Pt 2):R1371-82. (PMID: 7910436)
Diabetes. 2012 Sep;61(9):2238-47. (PMID: 22596049)
Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):85-9. (PMID: 12524229)
Tech Coloproctol. 2020 Jun;24(6):553-562. (PMID: 32112244)
Trends Endocrinol Metab. 2015 Nov;26(11):657-668. (PMID: 26482876)
FASEB J. 2020 Jul;34(7):9755-9770. (PMID: 32510702)
Endocrine. 2015 Nov;50(2):413-23. (PMID: 25784389)
J Biol Chem. 2004 Jan 9;279(2):1304-9. (PMID: 14557259)
Cell Mol Immunol. 2018 Jun;15(6):630-639. (PMID: 28626237)
Nat Med. 2009 Aug;15(8):921-9. (PMID: 19633657)
J Clin Endocrinol Metab. 2006 Aug;91(8):3165-70. (PMID: 16720654)
Nature. 2015 Mar 12;519(7542):242-6. (PMID: 25533952)
J Physiol Pharmacol. 2018 Oct;69(5):. (PMID: 30683819)
Circ Res. 2011 Sep 30;109(8):830-40. (PMID: 21868694)
J Biol Chem. 2003 Nov 7;278(45):45021-6. (PMID: 12944390)
FASEB J. 2015 Jan;29(1):141-51. (PMID: 25300621)
Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec;393(12):2279-2292. (PMID: 32651660)
J Clin Invest. 2009 Mar;119(3):531-9. (PMID: 19188682)
J Biol Chem. 2008 Sep 5;283(36):24889-98. (PMID: 18632660)
F1000Res. 2020 Feb 20;9:. (PMID: 32148771)
Science. 2005 Jan 21;307(5708):426-30. (PMID: 15604363)
Nat Commun. 2019 Jul 22;10(1):3254. (PMID: 31332184)
Nat Commun. 2018 Jun 25;9(1):2463. (PMID: 29941886)
Diabetes. 2012 Nov;61(11):2823-32. (PMID: 22837305)
J Clin Ultrasound. 2010 May;38(4):190-5. (PMID: 20091697)
Obes Surg. 2018 Nov;28(11):3484-3491. (PMID: 29931482)
Endocr Rev. 2017 Feb 1;38(1):46-68. (PMID: 27849358)
Mol Cell Endocrinol. 2020 Aug 1;513:110872. (PMID: 32454192)
J Allergy Clin Immunol. 2017 Jan;139(1):335-346.e3. (PMID: 27372564)
Br J Pharmacol. 2008 Jul;154(5):1035-46. (PMID: 18587448)
Immunology. 2019 Sep;158(1):3-18. (PMID: 31220342)
Mol Endocrinol. 2015 Jan;29(1):130-9. (PMID: 25389910)
EBioMedicine. 2017 Jun;20:137-149. (PMID: 28579299)
Diabetologia. 2016 Jun;59(6):1075-88. (PMID: 27039901)
JCI Insight. 2017 Feb 23;2(4):e89044. (PMID: 28239649)
FASEB J. 1999 Jul;13(10):1231-8. (PMID: 10385613)
Nat Med. 2012 Sep;18(9):1407-12. (PMID: 22863787)
Nat Metab. 2019 Mar;1(3):340-349. (PMID: 30887000)
Diabetes Obes Metab. 2011 Apr;13(4):348-56. (PMID: 21205128)
Cardiovasc Diabetol. 2015 Oct 09;14:137. (PMID: 26453464)
Sci Rep. 2020 Jan 21;10(1):878. (PMID: 31965030)
Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1121-E1130. (PMID: 31573841)
Mol Cell Biochem. 2007 Oct;304(1-2):243-8. (PMID: 17534697)
J Med Invest. 2017;64(3.4):193-196. (PMID: 28954980)
Nat Commun. 2020 Jun 10;11(1):2922. (PMID: 32523103)
Free Radic Res. 2003 Aug;37(8):809-14. (PMID: 14567439)
Mol Nutr Food Res. 2016 Jan;60(1):43-57. (PMID: 26331761)
Cardiovasc Diagn Ther. 2014 Dec;4(6):416-29. (PMID: 25610800)
Mol Cell Biol. 2013 Jan;33(2):328-39. (PMID: 23149942)
Cell Metab. 2006 Mar;3(3):223-9. (PMID: 16517409)
Inflammation. 2018 Mar;41(2):626-642. (PMID: 29264745)
Heart Vessels. 2009 Nov;24(6):446-53. (PMID: 20108078)
Am J Physiol. 1994 Mar;266(3 Pt 2):R831-7. (PMID: 8160878)
J Biol Chem. 2014 Mar 7;289(10):7011-7024. (PMID: 24469453)
J Mol Med (Berl). 2012 Feb;90(2):175-86. (PMID: 21964948)
Nat Cell Biol. 2014 Apr;16(4):367-75. (PMID: 24609269)
Br J Pharmacol. 2017 Oct;174(20):3514-3526. (PMID: 28236429)
Metabolism. 2007 Apr;56(4):451-8. (PMID: 17378999)
Allergy. 2020 Jun;75(6):1361-1370. (PMID: 31856334)
Cell. 2018 Jan 11;172(1-2):22-40. (PMID: 29328913)
J Leukoc Biol. 2013 Nov;94(5):877-84. (PMID: 23924659)
Cell Metab. 2014 Dec 2;20(6):991-1005. (PMID: 25470547)
Physiol Genomics. 2010 Jun;42(1):55-66. (PMID: 20215417)
Int Immunol. 2020 May 30;32(6):407-419. (PMID: 32147688)
Gastroenterology. 2012 Oct;143(4):1061-72. (PMID: 22705178)
Nat Med. 2017 May;23(5):623-630. (PMID: 28414329)
J Am Heart Assoc. 2019 Jan 22;8(2):e011147. (PMID: 30638109)
Obesity (Silver Spring). 2016 Jun;24(6):1274-82. (PMID: 27133873)
Cell. 2019 Jul 25;178(3):686-698.e14. (PMID: 31257031)
Front Immunol. 2019 Apr 25;10:775. (PMID: 31073300)
Int Arch Allergy Immunol. 2011;155(4):335-44. (PMID: 21346363)
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):682-91. (PMID: 26868208)
PLoS One. 2017 Feb 3;12(2):e0171293. (PMID: 28158227)
Biomed Res Int. 2019 Oct 31;2019:7157865. (PMID: 31781638)
Biomedicines. 2020 May 14;8(5):. (PMID: 32423179)
Front Immunol. 2016 Nov 24;7:524. (PMID: 27933062)
Sci Rep. 2018 Jul 2;8(1):9894. (PMID: 29967467)
Cell Mol Neurobiol. 2018 Jan;38(1):349-361. (PMID: 28801784)
Mediators Inflamm. 2008;2008:109502. (PMID: 19148295)
Cardiovasc Res. 2016 May 1;110(1):51-61. (PMID: 26825554)
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1425-37. (PMID: 21765057)
Front Immunol. 2018 Feb 05;9:141. (PMID: 29459863)
Lipids Health Dis. 2016 Feb 18;15:33. (PMID: 26965176)
FASEB J. 2016 May;30(5):1987-99. (PMID: 26873938)
Diabetologia. 2017 Oct;60(10):2033-2041. (PMID: 28660492)
Am J Physiol Endocrinol Metab. 2016 Apr 15;310(8):E676-E687. (PMID: 26884382)
J Endocrinol. 2007 Apr;193(1):137-45. (PMID: 17400811)
Circulation. 2003 Nov 18;108(20):2460-6. (PMID: 14581396)
Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C365-C376. (PMID: 30624981)
J Atheroscler Thromb. 2010 Feb 26;17(2):115-30. (PMID: 20145358)
Crit Rev Food Sci Nutr. 2017 Oct 13;57(15):3218-3232. (PMID: 26528631)
Immunity. 2017 Feb 21;46(2):273-286. (PMID: 28228283)
J Clin Invest. 1996 Jun 15;97(12):2898-904. (PMID: 8675704)
Gastroenterology. 2013 Aug;145(2):366-74.e1-3. (PMID: 23597726)
FASEB J. 2009 Jan;23(1):241-58. (PMID: 18787108)
Pathog Dis. 2016 Aug;74(6):. (PMID: 27297969)
J Clin Endocrinol Metab. 2004 Aug;89(8):3943-8. (PMID: 15292331)
Endocr Rev. 2018 Apr 1;39(2):79-132. (PMID: 29518206)
Am J Transl Res. 2015 Oct 15;7(10):1712-23. (PMID: 26692919)
Front Immunol. 2018 Jun 21;9:1404. (PMID: 30013547)
Obesity (Silver Spring). 2010 Oct;18(10):1918-25. (PMID: 20111012)
Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R934-42. (PMID: 15155276)
Cell Metab. 2016 Sep 13;24(3):510-519. (PMID: 27593966)
Nat Immunol. 2017 Jun;18(6):665-674. (PMID: 28459435)
Int J Obes (Lond). 2015 Oct;39(10):1548-57. (PMID: 25994806)
Eur J Epidemiol. 2004;19(1):9-13. (PMID: 15012018)
J Int Med Res. 2019 Jun;47(6):2571-2579. (PMID: 31081425)
Immunity. 2018 Feb 20;48(2):258-270.e5. (PMID: 29452935)
Trends Endocrinol Metab. 2016 Nov;27(11):782-795. (PMID: 27444065)
Circulation. 2007 Feb 27;115(8):1029-38. (PMID: 17296858)
Front Endocrinol (Lausanne). 2016 Apr 13;7:30. (PMID: 27148161)
Biochem Biophys Res Commun. 2010 Mar 19;393(4):668-72. (PMID: 20170632)
Diabetes. 2010 Apr;59(4):1030-7. (PMID: 20068138)
Trends Immunol. 2019 Sep;40(9):857-872. (PMID: 31399336)
Int J Obes Relat Metab Disord. 2004 Jan;28(1):173-5. (PMID: 14569276)
Atherosclerosis. 2013 Jun;228(2):451-9. (PMID: 23562132)
Eur J Immunol. 2012 Jan;42(1):120-9. (PMID: 22009734)
Int J Obes (Lond). 2019 Jun;43(6):1281-1294. (PMID: 30301967)
Cardiovasc Diabetol. 2019 Dec 5;18(1):167. (PMID: 31805941)
Cell Metab. 2017 Oct 3;26(4):672-685.e4. (PMID: 28918936)
Annu Rev Immunol. 2012;30:39-68. (PMID: 22136167)
Am J Physiol Regul Integr Comp Physiol. 2013 Sep;305(5):R490-8. (PMID: 23842679)
Cell Rep. 2019 Apr 2;27(1):226-237.e4. (PMID: 30943404)
Diabetes. 2012 Sep;61(9):2330-9. (PMID: 22851575)
Diabetes. 2016 Nov;65(11):3440-3452. (PMID: 27561727)
Biochem Biophys Res Commun. 2012 Nov 9;428(1):155-9. (PMID: 23068097)
Nat Rev Immunol. 2011 Oct 10;11(11):738-49. (PMID: 21984069)
Cell. 2015 Jan 15;160(1-2):74-87. (PMID: 25543153)
Nutr J. 2012 Nov 21;11:98. (PMID: 23171320)
Cell Metab. 2017 Apr 4;25(4):811-822.e4. (PMID: 28380374)
J Clin Endocrinol Metab. 2006 Nov;91(11):4223-31. (PMID: 16954156)
J Clin Invest. 2003 Dec;112(12):1796-808. (PMID: 14679176)
Circ Res. 2008 Aug 29;103(5):467-76. (PMID: 18658050)
J Clin Invest. 2017 Jan 3;127(1):74-82. (PMID: 28045400)
Cell Metab. 2018 Sep 4;28(3):463-475.e4. (PMID: 30184486)
Hypertension. 2016 Aug;68(2):478-90. (PMID: 27296996)
Genes Dev. 2012 Feb 1;26(3):271-81. (PMID: 22302939)
Nature. 2001 Jan 18;409(6818):307-12. (PMID: 11201732)
Diabetologia. 2018 Jan;61(1):220-230. (PMID: 29046921)
Exp Ther Med. 2020 Feb;19(2):1095-1102. (PMID: 32010275)
J Clin Invest. 2011 Jun;121(6):2111-7. (PMID: 21633179)
Cardiovasc Diabetol. 2011 Jul 07;10:61. (PMID: 21736746)
FEBS Lett. 2002 Dec 18;532(3):345-50. (PMID: 12482590)
Cell Metab. 2019 Apr 2;29(4):844-855.e3. (PMID: 30595477)
Obes Res Clin Pract. 2018 Nov - Dec;12(6):513-519. (PMID: 30115554)
Blood. 2006 Jun 1;107(11):4458-65. (PMID: 16449529)
Neuro Endocrinol Lett. 2019 Oct 08;40(Suppl1):49-55. (PMID: 31785227)
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):133-137. (PMID: 30967686)
Nature. 1998 Aug 27;394(6696):897-901. (PMID: 9732873)
Front Endocrinol (Lausanne). 2020 Apr 15;11:185. (PMID: 32351446)

Keywords: adipose tissue; adipose tissue browning; adipose tissue immunology; adipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammation; immunometabolism

Date Created: 20201207 Latest Revision: 20241003

20241003

PMC7705180

10.3389/fcvm.2020.602088

33282920